Physiomics Share Discussion Threads

[shares188] 28/9/2020 15:34

Stig,
You're making it worse!!!

[albert3591] 28/9/2020 10:47

And another tick down. All these ticks I am beginning to think pyc has Tourette’s.

[albert3591] 28/9/2020 10:45

All the optimism but no result,as per usual.Say things often enough you will start believing it’s true.I won’t and 100p will not happen.

[the stigologist] 28/9/2020 10:39

I'm expecting an RNS in the next few days from PYC

1. Confirming they have Share of ANY future licensing income from VAL201 (Upfronts, Milestones, Royalties)

2. To do further Modelling and Simulation work with VAL on 'optimising dosing schedules' going forward

This will transform market perception of Physiomics

That is why they are doing an Investor Presentation next week

This exciting and significant news needs getting out there

People who read the 100p Manifesto will be ahead of the game

Also still news on Cancer AI trials to come

[albert3591] 28/9/2020 10:34

Here we go as usual

[the stigologist] 28/9/2020 10:33

Maybe the Market is realising VAL has gone up over 1000% on excitement over VAL201

but PYC hasn't move yet and PYC have FREE CARRIED INTEREST.

Access to UPSIDE with no downside of funding/dilution

Indeed PYC could have TRIPLE WHAMMY Upside !

[justtrying1] 28/9/2020 10:10

Val red now pyc soon to follow

[albert3591] 28/9/2020 09:14

It would look like a bit of a rise each morning get some buys in then drop again.

[the stigologist] 28/9/2020 08:05

IF (big IF)

VAL201 is licensed for say total headline figure of $100m

Physiomics could be entitled to 1.25% ? 2.5% ? 5% ?

Any number of that type would be utterly TRANSFORMATIONAL for our business model and finances

This becomes a total Company maker !

The 100p Manifesto was indeed visionary !

[the stigologist] 28/9/2020 07:54

NOTE

Physiomics earlier this year signed a deal with the No.1 Prostate Cancer drug seller Astellas (Xtandi (enzalutamide) which sells $3bn p.a.)

Could they be a bridge for VAL to approach Astellas with regard to partnering VAL201 with Xtandi ?

[1airbag] 28/9/2020 07:50

markth - read points 1 / 2 / 3 in post above yours, they used the PYC tech to develop the drug VAL 201 (which has been shown as successful in trials) and in return PYC negotiated a cut of the revenues without needing to fund development costs.

PYC is a £7.5m company....! Prostate Cancer is the big one for men.

[markth126] 28/9/2020 07:23

Why have we got this, did we buy into VAL? Or given to us for services

[the stigologist] 28/9/2020 07:19

Triple Whammy good news for PYC from VAL news

1. ORR of 50% is very good early result. Shows promise to get VAL201 licensed to a bigger player. Physiomics get FREE CARRIED UPSIDE and share of ANY licensing income (including upfronts, milestones, royalties)

2. Note VAL comment on 'optimal dosing strategies'. Given PYC helped them develop drug in first place Physiomics should get follow on work now to develop these 'optimal dosing strategies' given Physiomics are experts in Modelling and Simulation of exactly that

3. In considering Partnering Physiomics modelling expertise can also be used to model which drug will work best in combination with VAL201 and this can be used to narrow search for best partner.

[markth126] 28/9/2020 07:13

How's it good here

[montynj] 28/9/2020 07:13

Positive results from VAL which is good for PYC

[peakytraders_14] 27/9/2020 21:38

Does ur mumma punnani smell of tuna?

[peakytraders_14] 27/9/2020 21:34

Is Albert giving ur dad a BJ

[peakytraders_14] 27/9/2020 21:34

You want another final warning from.ADVFN?